Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing

Novel agents have increased survival of multiple myeloma (MM) patients, however high-risk and relapsed/refractory patients remain challenging to treat and their outcome is poor. To identify novel therapies and aid treatment selection for MM, we assessed the ex vivo sensitivity of 50 MM patient sampl...

Descripción completa

Detalles Bibliográficos
Autores principales: Majumder, Muntasir Mamun, Silvennoinen, Raija, Anttila, Pekka, Tamborero, David, Eldfors, Samuli, Yadav, Bhagwan, Karjalainen, Riikka, Kuusanmäki, Heikki, Lievonen, Juha, Parsons, Alun, Suvela, Minna, Jantunen, Esa, Porkka, Kimmo, Heckman, Caroline A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593565/
https://www.ncbi.nlm.nih.gov/pubmed/28915594
http://dx.doi.org/10.18632/oncotarget.17630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593565/
https://www.ncbi.nlm.nih.gov/pubmed/28915594
http://dx.doi.org/10.18632/oncotarget.17630

Ejemplares similares